Department of Urology, University of Iowa, Iowa City, IA 52242-1089, USA.
BJU Int. 2012 Mar;109(5):700-5. doi: 10.1111/j.1464-410X.2011.10452.x. Epub 2011 Jul 20.
• To evaluate the utility of the RENAL scoring system in predicting operative approach and risk of complications. The RENAL nephrometry scoring system is designed to allow comparison of renal masses based on the radiological features of (R)adius, (E)xophytic/endophytic, (N)earness to collecting system, (A)nterior/posterior and (L)ocation relative to polar lines.
• A retrospective review of all patients at a single institution undergoing radical nephrectomy (RN) or partial nephrectomy (PN) for a renal mass between July 2007 and May 2010 was carried out. • Preoperative RENAL score was calculated for each patient. Surgical approach and operative outcomes were then compared with the RENAL score.
• In all, 249 patients underwent either RN (158) or PN (91) with average RENAL scores of 8.9 and 6.3, respectively (P < 0.001). • Patients who underwent RN were more likely to have hilar tumours (64% vs 10%, P < 0.001) than patients who underwent PN, but were no more likely to have posteriorly located tumours (50% each). • There were more complications among patients with RN (58%) vs patients with PN (42%, P= 0.02). • RENAL scores were higher in patients with PN who developed complications than in patients with PN who did not develop complications (6.9 vs 6.0, P= 0.02), with no difference noted among patients with RN developing complications (8.9 vs 8.9, P= 0.99).
• The RENAL system accurately predicted surgeon operative preference and risk of complications for patients undergoing PN.
评估 RENAL 评分系统在预测手术方式和并发症风险方面的效用。RENAI 肾肿瘤影像学评分系统旨在根据肿瘤的(R)adius(半径)、(E)xophytic/endophytic(外生性/内生性)、(N)earness to collecting system(临近收集系统)、(A)nterior/posterior(前后)和(L)ocation relative to polar lines(相对于极线的位置)等影像学特征对肾肿瘤进行比较。
对 2007 年 7 月至 2010 年 5 月期间在一家机构接受根治性肾切除术(RN)或部分肾切除术(PN)治疗的所有肾肿瘤患者进行回顾性分析。对每位患者进行术前 RENAL 评分。然后比较手术方式和手术结果与 RENAL 评分的关系。
共 249 例患者接受 RN(158 例)或 PN(91 例)治疗,平均 RENAL 评分分别为 8.9 和 6.3(P<0.001)。接受 RN 治疗的患者更可能患有肾门肿瘤(64%比 10%,P<0.001),而接受 PN 治疗的患者则更不可能患有后位肿瘤(各占 50%)。接受 RN 治疗的患者(58%)比接受 PN 治疗的患者(42%)更易发生并发症(P=0.02)。发生并发症的 PN 患者的 RENAL 评分高于未发生并发症的 PN 患者(6.9 比 6.0,P=0.02),而发生并发症的 RN 患者的 RENAL 评分无差异(8.9 比 8.9,P=0.99)。
RENAI 系统能准确预测接受 PN 治疗的患者的手术偏好和并发症风险。